Concepedia

Kathy Hasenbach

KH

Statistics

Publications

9

Citations

384

H-Index

9

Active since

2010

Affiliations

University Hospital of Zurich(Current)

University of Tübingen

University of Zurich

Isarna Therapeutics (Germany)

Hertie Institute for Clinical Brain Research

Kathy Hasenbach is an author at University Hospital of Zurich specializing in oncology, medicine, and molecular oncology.

Publications per year

2010–2019

9

Publications

9

Integrin control of the transforming growth factor-β pathway in glioblastoma

Patrick Roth, Manuela Silginer, Simon L. Goodman et al. · Brain · 2013 · 106 citations · Full text

, , +17

Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma

Katharina Seystahl, Alexandros Papachristodoulou, Isabel Burghardt et al. · Molecular Cancer Therapeutics · 2017 · 60 citations

, , +14

Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma

Hans‐Georg Wirsching, Shanmugarajan Krishnan, Ana‐Maria Florea et al. · Brain · 2013 · 52 citations · Full text

, , +17

APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo

Günter Eisele, Peter Roth, Kathy Hasenbach et al. · Neuro-Oncology · 2010 · 49 citations · Full text

, , +16

Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas

Alexandros Papachristodoulou, Manuela Silginer, Michael Weller et al. · Clinical Cancer Research · 2019 · 49 citations

, , +15

1–5 of 9